Mike Sharland

42.8k total citations · 4 hit papers
367 papers, 11.5k citations indexed

About

Mike Sharland is a scholar working on Epidemiology, Applied Microbiology and Biotechnology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Mike Sharland has authored 367 papers receiving a total of 11.5k indexed citations (citations by other indexed papers that have themselves been cited), including 181 papers in Epidemiology, 111 papers in Applied Microbiology and Biotechnology and 102 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Mike Sharland's work include Antibiotic Use and Resistance (111 papers), Pneumonia and Respiratory Infections (87 papers) and Antibiotics Pharmacokinetics and Efficacy (74 papers). Mike Sharland is often cited by papers focused on Antibiotic Use and Resistance (111 papers), Pneumonia and Respiratory Infections (87 papers) and Antibiotics Pharmacokinetics and Efficacy (74 papers). Mike Sharland collaborates with scholars based in United Kingdom, Switzerland and United States. Mike Sharland's co-authors include Julia Bielicki, Paul T. Heath, Sonia Saxena, Diana M. Gibb, Yingfen Hsia, Michael Burch, Charlotte Barker, Jon S. Friedland, Alan P. Johnson and Ian Chi Kei Wong and has published in prestigious journals such as Nature, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

Mike Sharland

355 papers receiving 11.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Assessment of WHO antibiotic consumption and access targets in 76 countries, 2000–15: an analysis of pharmaceutical sales data

2020 318 citations Mike Sharland, Sumanth Gandra et al. profile →
The scope of the antimicrobial resistance challenge

2024 179 citations Mike Sharland et al. profile →
The <i>WHO AWaRe (Access, Watch, Reserve) antibiotic book</i> and prevention of antimicrobial resistance

2023 124 citations Mike Sharland, Sumanth Gandra et al. profile →
Ensuring progress on sustainable access to effective antibiotics at the 2024 UN General Assembly: a target-based approach

2024 46 citations Mike Sharland, Ramanan Laxminarayan et al. profile →

Peers

Countries citing papers authored by Mike Sharland

Since Specialization

Citations

This map shows the geographic impact of Mike Sharland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mike Sharland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mike Sharland more than expected).

Fields of papers citing papers by Mike Sharland

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mike Sharland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mike Sharland. The network helps show where Mike Sharland may publish in the future.

Co-authorship network of co-authors of Mike Sharland

This figure shows the co-authorship network connecting the top 25 collaborators of Mike Sharland. A scholar is included among the top collaborators of Mike Sharland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mike Sharland. Mike Sharland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Burden of Neonatal Invasive Candidiasis in Low- and Middle-income Countries: A Systematic Review and Meta-analysis 2025 ·Open Forum Infectious Diseases ·Daniel Hsiang‐Te Tsai, (unknown), (unknown), Minmin Lü, (unknown), Nelesh P. Govender, Mike Sharland, Adilia Warris, Yingfen Hsia, Laura Ferreras	0
2	Diagnostic and antibiotic use practices among COVID-19 and non-COVID-19 patients in the Indonesian National Referral Hospital 2024 ·PLoS ONE ·Robert Sinto, (unknown), (unknown), Suhendro Suwarto, Erni Juwita Nelwan, Mulya Rahma Karyanti, Anis Karuniawati, (unknown), Ari Prayitno, (unknown), Mike Sharland, Catrin E. Moore, Raph L Hamers, Nicholas Day, Direk Limmathurotsakul	3
3	Determining sample size in a personalized randomized controlled (PRACTical) trial 2024 ·Statistics in Medicine ·Rebecca Turner, (unknown), A. Sarah Walker, Sally Ellis, Mike Sharland, Julia Bielicki, Wolfgang Stöhr, Ian R. White	2
4	The Neonatal and Paediatric Pharmacokinetics of Antimicrobials study (NAPPA): investigating amoxicillin, benzylpenicillin, flucloxacillin and piperacillin pharmacokinetics from birth to adolescence 2023 ·Journal of Antimicrobial Chemotherapy ·Charlotte Barker, Karin Kipper, D Lonsdale, (unknown), (unknown), Min Kim, M. Turner, A. E. Johnston, Mike Sharland, Joseph F. Standing	5
5	Randomised controlled trial of fosfomycin in neonatal sepsis: pharmacokinetics and safety in relation to sodium overload 2022 ·Archives of Disease in Childhood ·Christina W. Obiero, Phoebe Williams, (unknown), Johnstone Thitiri, Raymond Omollo, A. Sarah Walker, Thaddaeus Egondi, (unknown), Erika Correia, (unknown), Silke Gastine, Karin Kipper, Joseph F. Standing, Sally Ellis, Mike Sharland, James A. Berkley	13
6	Assessment of flomoxef combined with amikacin in a hollow-fibre infection model for the treatment of neonatal sepsis in low- and middle-income healthcare settings 2022 ·Journal of Antimicrobial Chemotherapy ·(unknown), Laura McEntee, Adam Johnson, Nicola Farrington, (unknown), (unknown), (unknown), Ruwanthi Kolamunnage‐Dona, (unknown), Sally Ellis, F. Franceschi, Mike Sharland, Michael Neely, Laura J. V. Piddock, Shampa Das, William Hope	3
7	Antibiotic Prescription Patterns in the Paediatric Primary Care Setting before and after the COVID-19 Pandemic in Italy: An Analysis Using the AWaRe Metrics 2022 ·Antibiotics ·Elisa Barbieri, (unknown), Anna Cantarutti, Costanza Di Chiara, Angela Lupattelli, Mike Sharland, Carlo Giaquinto, Yingfen Hsia, Daniele Donà	18
8	Amoxicillin duration and dose for community-acquired pneumonia in children: the CAP-IT factorial non-inferiority RCT 2021 ·Health Technology Assessment ·(unknown), Julia Bielicki, David Dunn, Saul N. Faust, Adam Finn, Lynda Harper, (unknown), Mark D Lyttle, Colin Powell, Louise Rogers, Damian Roland, Wolfgang Stöhr, Kate Sturgeon, (unknown), Mandy Wan, Diana M. Gibb, Mike Sharland	7
9	High global consumption of potentially inappropriate fixed dose combination antibiotics: Analysis of data from 75 countries 2021 ·PLoS ONE ·Barbara Bortone, Charlotte Jackson, Yingfen Hsia, Julia Bielicki, Nicola Magrini, Mike Sharland	32
10	β-Lactam antimicrobial pharmacokinetics and target attainment in critically ill patients aged 1 day to 90 years: the ABDose study 2020 ·Journal of Antimicrobial Chemotherapy ·D Lonsdale, Karin Kipper, Emma H. Baker, Charlotte Barker, (unknown), Barbara J. Philips, A. E. Johnston, Andrew Rhodes, Mike Sharland, Joseph F. Standing	19
11	Population pharmacokinetic meta-analysis of individual data to design the first randomized efficacy trial of vancomycin in neonates and young infants 2019 ·Journal of Antimicrobial Chemotherapy ·Évelyne Jacqz-Aigrain, Stéphanie Leroux, Alison H. Thomson, Karel Allegaert, Edmund V. Capparelli, Valérie Biran, Nicolas Simon, Bernd Meibohm, Yoke Lin Lo, (unknown), José‐Esteban Peris, Irja Lutsar, Jumpei Saito, Hidefumi Nakamura, Johannes N. van den Anker, Mike Sharland, Wei Zhao	35
12	Scaling beta‐lactam antimicrobial pharmacokinetics from early life to old age 2018 ·British Journal of Clinical Pharmacology ·D Lonsdale, Emma H. Baker, Karin Kipper, Charlotte Barker, Barbara J. Philips, Andrew Rhodes, Mike Sharland, Joseph F. Standing	16
13	The ethics of setting national antibiotic policies using financial incentives 2017 ·British Journal of General Practice ·Grace Li, (unknown), Andrew Papanikitas, Susan Hopkins, Mike Sharland	4
14	Point Prevalence Surveys of Antimicrobial Use among Hospitalized Children in Six Hospitals in India in 2016 2017 ·Antibiotics ·Sumanth Gandra, Sanjeev Singh, Dasaratha Ramaiah Jinka, Ravishankar Kanithi, (unknown), Anita Sharma, Dhanya Dharmapalan, Anil Vasudevan, (unknown), (unknown), Garima Garg, Yingfen Hsia, Srinivas Murki, Gerardo Alvarez‐Uria, Mike Sharland, Ramanan Laxminarayan	40
15	A Risk Assessment of Antibiotic Pan-Drug-Resistance in the UK: Bayesian Analysis of an Expert Elicitation Study 2017 ·Antibiotics ·(unknown), André Charlett, Stefano Conti, Julie V. Robotham, Alan P. Johnson, David M. Livermore, Tom Fowler, Mike Sharland, Susan Hopkins, Neil Woodford, (unknown), (unknown)	16
16	Do We Know When, What and For How Long to Treat? 2012 ·The Pediatric Infectious Disease Journal ·Susanna Esposito, Robert Cohen, Javier Díez‐Domingo, (unknown), David Greenberg, Ulrich Heininger, Markus Knuf, Irja Lutsar, Nicola Principi, Fernanda Rodrigues, Mike Sharland, Vana Spoulou, George A. Syrogiannopoulos, Vytautas Usonis, Anne Vergison, Urs B. Schaad	87
17	Effect of antibiotics for otitis media on mastoiditis in children: A retrospective cohort study using the UK General Practice Research Database 2008 ·UCL Discovery (University College London) ·(unknown), Ruth Gilbert, (unknown), Sonia Saxena, Mike Sharland, Ian Chi Kei Wong	1
18	,on behalf of CHIPS and NSHPC. Changes in vertically acquired paediatric HIV in UK and Ireland over calendar time: the Collaborative HIV Paediatric Surveillance (CHIPS) Study and the National Study of HIV in Pregnancy and Childhood (NSHPC) 2003 ·UCL Discovery (University College London) ·Katja Doerholt, (unknown), Mike Sharland, (unknown), José Carlos Amado Martins, Diana M. Gibb	1
19	Lone parent families are an independent risk factor for lower rates of childhood immunisation in London. 1997 ·PubMed ·Mike Sharland, P L Atkinson, Helen Maguire, Norman Begg	21
20	GENETIC-COUNSELING IN NOONAN SYNDROME 1991 ·UCL Discovery (University College London) ·Mike Sharland, (unknown), M. Burch, William J. McKenna, (unknown)	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact